Ayşegül Özdoğan Bircan

Ayşegül Özdoğan Bircan

Auto-generated profile, based on publicly available information

Ayşegül Özdoğan Bircan

Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Cukurova University, Adana, Turkey

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in Archives of Rheumatology
Verified
Journal Article
Open access
PDF file
ABAyşegül Özdoğan Bircan
Ayşegül Özdoğan Bircan
ŞAŞerife Şeyda Zengin Acemoğlu
Şerife Şeyda Zengin Acemoğlu
ITİpEk Türk
İpEk Türk
HÖHüseyin Turgut Elbek Özer
Hüseyin Turgut Elbek Özer
Background/Aims: Primary Sjögren’s syndrome (pSS) is an autoimmune disease that can affect several systems. The purpose of this study was to examine the connection between primary Sjögren’s disease activity and the CRP-albumin-lymphocyte index (CALLY) and the HALP (hemoglobin, albumin, lymphocyte, and platelet) score, 2 novel immunonutritional indicators that have not yet been applied to rheumatological disease activation. Materials and Methods: This cross-sectional study included 89 patients with pSS and 113 age- and sex-matched individuals. The relationship between haematological, inflammatory, immunonutritional biomarkers, and disease activation was investigated, as were the differences between the groups. Results: Eighty-nine patients (96.6% female, mean age 53.4 ± 15.0 years) and 113 control subjects (97.3% female, mean age 50.8 ± 14.9 years) were included in the study. The levels of C-reactive protein (CRP), erythrocyte sedimentation rate, red cell distribution width, neutrophil lymphocyte ratio, monocyte lymphocyte ratio, platelet lymphocyte ratio, and C-reactive protein albumin ratio were significantly higher in the group of patients with pSS compared to the control group (all; P < .001). Systemic immuneinflammation index and systemic inflammatory response index were significantly elevated in the patient cohort compared to the control group (P = .002 and P = .048, respectively). The CALLY index and HALP score were negatively correlated with EULAR Sjögren’s syndrome disease activity index (P < .001 for both). Conclusion: The CALLY index and HALP score represent a novel approach to assessing disease activity and prognosis in a number of conditions, including stroke, myocardial infarction, osteoarthritis, pulmonary thromboembolism, asthma, chronic obstructive pulmonary disease, and many types of cancer. They may also be useful as a guide to disease activity and monitoring in pSS.

24 March 2023 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
ŞAŞerife Şeyda Zengin Acemoğlu
Şerife Şeyda Zengin Acemoğlu
ITİpEk Türk
İpEk Türk
MAMehmet Ali Aşık
Mehmet Ali Aşık
ABAyşegül Özdoğan Bircan
Ayşegül Özdoğan Bircan
PDPelin pınar Pinar Deniz
Pelin pınar Pinar Deniz
IÜİlKer Ünal
İlKer Ünal

15 April 2025 in Rheumatology International
Verified
Journal Article
Open access
PDF file
SASerife Seyda Zengin Acemoglu
Serife Seyda Zengin Acemoglu
ABAyşegül Özdoğan Bircan
Ayşegül Özdoğan Bircan
ITİpEk Türk
İpEk Türk
IBIlke Coskun Benlidayi
Ilke Coskun Benlidayi
SASariyildiz Aylin
Sariyildiz Aylin
IÜİlKer Ünal
İlKer Ünal
The aim of this study was to explore the link between fear of falling and factors that may contribute to falls in patients with primary Sjögren’s syndrome (pSS). Our study included a total of 67 patients with pSS, aged between 18 and 65. The following tests were performed on each of them by the same researcher: (I) Pain Quality Assessment Scale (PQAS); (II) Berg Balance Scale (BBS); (III) Pittsburgh Sleep Quality Index (PSQI); (IV) Medical Outcomes Study 36-Item Short Form Health Survey (SF-36); (V) Tampa Kinesiophobia Fatigue Scale Questionnaire (TSK-F); (VI) International Falls Efficiency Scale (FES-I); (VII) Timed Up And Go Test (TUG). Disease activities were recorded using the EULAR Sjögren’s Syndrome Disease Activity Index (ESSDAI) criteria. The following factors were associated with a fear of falling: (I) Deterioration in sleep quality (p = 0.031), (II) A decline in general health perception (p < 0.001), (III) Increased severity of pain (p < 0.001), (IV) Kinesiophobia (p < 0.001), (V) Difficulties with timely getting up and walking (p < 0.001), (VI) Increased disease activity (p < 0.001). There is no information available regarding the prevalence or contributing factors of fear of falling in individuals with pSS. This is the first study to examine fear of falling and contributing factors cross-sectionally in a sample of adults with pSS. These findings could aid in the development of a screening instrument to find modifiable risk factors for individuals with pSS who are susceptible to falling anxiety.

22 June 2026 in Rheumatology International
Verified
Journal Article
Open access
MSMerve Erdoğan Soysal
Merve Erdoğan Soysal
ITIpek Turk
Ipek Turk
ABAyşegül Özdoğan Bircan
Ayşegül Özdoğan Bircan
MSMetehan Soysal
Metehan Soysal
To examine the relationship between oral handicap, clinical characteristics, psychosocial status, and quality of life in patients with systemic sclerosis (SSc). This cross-sectional study included 99 patients with SSc. Oral handicap was assessed using the Mouth Handicap in Systemic Sclerosis Scale (MHISS). Social appearance anxiety, anxiety/depression symptoms, resilience, and quality of life were evaluated using the Social Appearance Anxiety Scale, Hospital Anxiety and Depression Scale, Brief Resilience Scale, and World Health Organization Quality of Life–BREF (WHOQOL-BREF), respectively. Statistical and hierarchical multiple regression analyses were also performed. Oral handicap was associated with female sex (rho = 0.220, p = 0.029) and diffuse cutaneous SSc subtype (rho = − 0.482, p < 0.001). Oral handicap showed strong positive correlations with the facial and total modified Rodnan Skin Score (rho = 0.851 and rho = 0.737; both p < 0.001). Positive associations were also observed for gastrointestinal (GI) involvement, calcinosis, telangiectasia, Scl-70 positivity, and digital ulcers (p < 0.002 for all). MHISS scores were positively correlated with anxiety, depression, and social appearance anxiety, and negatively correlated with all WHOQOL-BREF domains (p < 0.001 for all). In the regression analyses, mRSS (β = 0.484, p < 0.001), GI involvement (β = 0.210, p = 0.006), and anxiety scores (β = 0.183, p = 0.036) remained independently associated with oral impairment. The clinical model explained an additional 54% of variance, with a further 5% contributed by psychosocial variables. Oral impairment in SSc reflects both clinical disease burden and psychosocial distress, underscoring its multifactorial nature.

19 May 2026 in Rheumatology International
Verified
Journal Article
Closed access
ABAyşegül Özdoğan Bi̇rcan
Ayşegül Özdoğan Bi̇rcan
BABişar Akbaş
Bişar Akbaş
ÖBÖvgü Bıçkıcı
Övgü Bıçkıcı
ITIpek Turk
Ipek Turk
FPFerhat Can Can Pişkin
Ferhat Can Can Pişkin
DADidem Arslan
Didem Arslan

27 January 2026 in Aktuelle Rheumatologie
Verified
Journal Article
Closed access
PDF file
ABAyşegül Özdoğan Bircan
Ayşegül Özdoğan Bircan
UEUfuk Mert Erginer
Ufuk Mert Erginer
ITİpEk Türk
İpEk Türk
ISIrem Sahinoglu
Irem Sahinoglu
HÖHüseyin Turgut Elbek Özer
Hüseyin Turgut Elbek Özer
Rheumatoid arthritis (RA) is an autoimmune disease characterised by systemic inflammation, with gastrointestinal symptoms being among the most common extra-articular manifestations. Functional gastrointestinal disorders (FGIDs), which occur in the absence of an organic cause, are reported more frequently in patients with autoimmune diseases. This study investigated the rate of FGIDs in RA patients, its relationship with RA disease activity, and its effect on the quality of life of RA patients. All RA patients completed the Rome IV questionnaire, the Short Form 12 (SF-12), and the Health Assessment Questionnaire (HAQ) to assess disease and general health. The Disease Activity Score (DAS 28), the number of tender and swollen joints, and acute-phase reactant levels were used to assess disease activity, with results recorded together with demographic data. Of the 115 RA patients, 54.8% had FGIDs, with the most common type being functional dyspepsia (FD) (39.1%). Other diagnoses included irritable bowel syndrome (16.5%), functional constipation (13.9%), and functional diarrhoea (7.8%). Patients with FGIDs had higher DAS28 scores compared to those without (median 3.77 [interquartile range: 2.68] vs. 2.96 [1.99]; p=0.017). After applying the Bonferroni correction for multiple tests (corrected significance level p<0.0042), we found that correlations between functional constipation and functional dyspepsia and quality of life outcomes were not statistically significant. FGIDs are common among RA patients and are associated with more severe symptoms and reduced quality of life. Their management may involve various strategies.